• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MTSS1 表达缺失是肝内胆管细胞癌的一个独立预后因素。

Loss of MTSS1 expression is an independent prognostic factor for Hilar cholangiocarcinoma.

机构信息

Department of Surgery, Eastern Hepatobiliary Hospital, Shanghai, China.

出版信息

Pathol Oncol Res. 2013 Oct;19(4):815-20. doi: 10.1007/s12253-013-9649-6. Epub 2013 Jul 14.

DOI:10.1007/s12253-013-9649-6
PMID:23852458
Abstract

Metastasis suppressor 1 (MTSS1) is a novel metastasis suppressor gene in a variety of cancers. This study aimed to detect MTSS1 expression in normal and cancerous tissue specimens from Chinese patients with hilarcholangiocarcinoma to determine the association with clinicopathological parameters and survival. Tissue microarrays containing normal and tumor specimens were constructed using paraffin blocks from 61 patients for immunohistochemical analysis of MTSS1 expression. A subgroup of these tissues was verified by Western blot analysis. MTSS1 protein was expressed in 24 of 61 cases (39.3 %) of tumor tissues, compared to that in 22 of 26 (84.6 %) of non-neoplastic bile duct epithelium and in 26 of 26 (100 %) of adjacent normal liver cells. Loss of MTSS1 expression was associated with lymph node metastases of cholangiocelluarcarcinoma and tumorcellde-differentiation.MTSS1 expression inversely associated with tumor recurrence and overall survival of the patients by univariate and multivariate analyses. MTSS1 expression was significantly decreased in human hilarcholangiocarcinoma and lost MTSS1 expression was associated with pooroverall survival and tumor recurrences in cholangiocarcinoma patients. Thus, MTSS1 expression represents an independent predictor for tumor recurrence and overall survival in patients with cholangiocarcinoma.

摘要

转移抑制因子 1(MTSS1)是多种癌症中一种新的转移抑制基因。本研究旨在检测中国肝内胆管癌患者正常和癌组织标本中 MTSS1 的表达,以确定其与临床病理参数和生存的关系。使用石蜡块构建包含正常和肿瘤标本的组织微阵列,用于 MTSS1 表达的免疫组织化学分析。对这些组织的一个亚组进行了 Western blot 分析。在 61 例肿瘤组织中的 24 例(39.3%)、26 例非肿瘤胆管上皮组织中的 22 例(84.6%)和 26 例相邻正常肝细胞中检测到 MTSS1 蛋白表达。MTSS1 表达缺失与胆管细胞癌的淋巴结转移和肿瘤细胞分化有关。单因素和多因素分析表明,MTSS1 表达与患者的肿瘤复发和总生存呈负相关。MTSS1 在人肝内胆管癌中表达明显降低,MTSS1 表达缺失与胆管癌患者的总生存和肿瘤复发不良相关。因此,MTSS1 表达是胆管癌患者肿瘤复发和总生存的独立预测因子。

相似文献

1
Loss of MTSS1 expression is an independent prognostic factor for Hilar cholangiocarcinoma.MTSS1 表达缺失是肝内胆管细胞癌的一个独立预后因素。
Pathol Oncol Res. 2013 Oct;19(4):815-20. doi: 10.1007/s12253-013-9649-6. Epub 2013 Jul 14.
2
High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.高迁移率族蛋白盒1在肝内胆管癌中的表达与淋巴结转移
World J Gastroenterol. 2015 Mar 21;21(11):3256-65. doi: 10.3748/wjg.v21.i11.3256.
3
Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.PRL-3 在人肝内胆管细胞癌中的表达及预后价值。
Pathol Oncol Res. 2010 Jun;16(2):169-75. doi: 10.1007/s12253-009-9200-y. Epub 2009 Sep 9.
4
The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.SOCS3和A20在人类胆管癌中的预后作用
PLoS One. 2015 Oct 20;10(10):e0141165. doi: 10.1371/journal.pone.0141165. eCollection 2015.
5
EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.EYA4基因作为一种预后标志物发挥作用,并抑制肝内胆管癌的生长。
Chin J Cancer. 2016 Jul 28;35(1):70. doi: 10.1186/s40880-016-0133-z.
6
Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.非典型蛋白激酶C-ι与E-钙黏蛋白表达与胆管癌侵袭及预后的相关性
Hepatobiliary Pancreat Dis Int. 2008 Feb;7(1):70-5.
7
Prognostic significance of snail expression in hilar cholangiocarcinoma.蜗牛表达在肝门部胆管癌中的预后意义。
Braz J Med Biol Res. 2012 Jul;45(7):617-24. doi: 10.1590/s0100-879x2012007500070. Epub 2012 May 10.
8
Overexpression of Sig1R is closely associated with tumor progression and poor outcome in patients with hilar cholangiocarcinoma.Sig1R的过表达与肝门部胆管癌患者的肿瘤进展及不良预后密切相关。
Med Oncol. 2014 Dec;31(12):261. doi: 10.1007/s12032-014-0261-8. Epub 2014 Oct 26.
9
Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.水通道蛋白-1在肝内胆管癌中的下调与肿瘤进展及黏蛋白表达有关。
Hum Pathol. 2007 Dec;38(12):1819-25. doi: 10.1016/j.humpath.2007.04.016. Epub 2007 Sep 14.
10
Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma.淋巴结微转移与其他方面淋巴结阴性的肝门部胆管癌患者较差的生存率相关。
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1107-15. doi: 10.1245/s10434-015-4723-9. Epub 2015 Jul 16.

引用本文的文献

1
MTSS1: beyond the integration of actin and membrane dynamics.MTSS1:超越肌动蛋白与膜动力学的整合
Cell Mol Life Sci. 2024 Dec 3;81(1):472. doi: 10.1007/s00018-024-05511-w.
2
Survival analysis of extrahepatic cholangiocarcinoma based on surveillance, epidemiology, and end results database.基于监测、流行病学和最终结果数据库的肝外胆管癌生存分析
Ann Hepatobiliary Pancreat Surg. 2023 May 31;27(2):151-157. doi: 10.14701/ahbps.22-090. Epub 2023 Jan 2.
3
Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.

本文引用的文献

1
Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma.肝门部胆管癌手术治疗中预后因素的单因素和多因素分析。
Am Surg. 2010 Nov;76(11):1260-8.
2
Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.肝内、肝门部和远端胆管癌手术切除后的预后因素。
Ann Surg Oncol. 2011 Mar;18(3):651-8. doi: 10.1245/s10434-010-1325-4. Epub 2010 Oct 14.
3
Annexin-1 downregulation is associated with clinical outcome in Chinese patients with hilar cholangiocarcinoma.
基因表达变化促成复发急性髓系白血病的干性和治疗抗性:SOCS2、CALCRL、MTSS1和KDM6A的作用
Exp Hematol. 2021 Jul;99:1-11. doi: 10.1016/j.exphem.2021.05.004. Epub 2021 May 21.
4
Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness.MTSS1 在急性髓细胞白血病中的下调与不良预后、化疗耐药和疾病侵袭性相关。
Leukemia. 2021 Oct;35(10):2827-2839. doi: 10.1038/s41375-021-01224-2. Epub 2021 Mar 29.
5
Overexpression of microRNA-96 is associated with poor prognosis and promotes proliferation, migration and invasion in cholangiocarcinoma cells via .微小RNA-96的过表达与不良预后相关,并通过……促进胆管癌细胞的增殖、迁移和侵袭。
Exp Ther Med. 2020 Apr;19(4):2757-2765. doi: 10.3892/etm.2020.8502. Epub 2020 Feb 7.
6
Metadherin overexpression in perihilar cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.肝门周围胆管癌中Metadherin的过表达与淋巴结转移及预后不良相关。
Oncol Lett. 2019 May;17(5):4514-4520. doi: 10.3892/ol.2019.10141. Epub 2019 Mar 12.
7
Missing-in-metastasis B (MIM-B) combined with caveolin-1 promotes metastasis of hepatocellular carcinoma.转移缺失蛋白B(MIM-B)与小窝蛋白-1共同促进肝细胞癌转移。
Oncotarget. 2017 Sep 8;8(56):95450-95465. doi: 10.18632/oncotarget.20735. eCollection 2017 Nov 10.
8
Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.MTSS1的缺失导致胰腺癌转移潜能增加。
Oncotarget. 2017 Mar 7;8(10):16473-16487. doi: 10.18632/oncotarget.14869.
9
Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma.AQP1 表达升高与肝门部胆管癌患者不良的肿瘤学结局相关。
Technol Cancer Res Treat. 2017 Aug;16(4):421-427. doi: 10.1177/1533034616646288. Epub 2016 May 2.
10
MTSS1 is an independent prognostic biomarker for survival in intrahepatic cholangiocarcinoma patients.MTSS1是肝内胆管癌患者生存的独立预后生物标志物。
Am J Transl Res. 2015 Oct 15;7(10):1974-83. eCollection 2015.
膜联蛋白-1下调与中国肝门部胆管癌患者的临床预后相关。
Eur Surg Res. 2010;45(3-4):151-7. doi: 10.1159/000320237. Epub 2010 Oct 6.
4
Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer.转移抑制因子 1(MTSS1)下调与中国胃癌患者的淋巴结转移和不良预后相关。
BMC Cancer. 2010 Aug 15;10:428. doi: 10.1186/1471-2407-10-428.
5
MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling.MIM 和 cortactin 拮抗作用调节纤毛发生和 hedgehog 信号通路。
Dev Cell. 2010 Aug 17;19(2):270-83. doi: 10.1016/j.devcel.2010.07.009.
6
Factors relating to the short term effectiveness of percutaneous biliary drainage for hilar cholangiocarcinoma.与经皮胆道引流治疗肝门部胆管癌短期疗效相关的因素。
World J Gastroenterol. 2009 Nov 7;15(41):5206-10. doi: 10.3748/wjg.15.5206.
7
CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.CD10+ 纤维母细胞在肝门部/肝外胆管癌的进展中比在周围型肝内胆管癌中更为活跃。
Histopathology. 2009 Oct;55(4):423-31. doi: 10.1111/j.1365-2559.2009.03398.x.
8
Hilar cholangiocarcinoma: current management.肝门部胆管癌:当前的治疗方法
Ann Surg. 2009 Aug;250(2):210-8. doi: 10.1097/SLA.0b013e3181afe0ab.
9
[Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma].[肝门部胆管癌手术疗效及预后因素分析]
Zhonghua Wai Ke Za Zhi. 2009 Jan 15;47(2):94-7.
10
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.基质金属蛋白酶在肝内胆管癌、肝门部(克氏壶腹肿瘤)、肝外胆管中下段癌、胆囊癌和壶腹癌中的表达:基质金属蛋白酶在肿瘤进展和预后中的作用
Turk J Gastroenterol. 2009 Mar;20(1):41-7.